Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New insights into canine liver disease
Image dog eye close up
Researchers say the findings provide a base for developing new treatments.
Researchers shed light on the causes of neurological abnormalities

Researchers have uncovered new insights into the causes of neurological abnormalities arising from canine liver disease.

As part of a new study, the Royal (Dick) School of Veterinary Studies has joined forces with the RVC to further understand why dogs may suffer from these complications.

Neurological abnormalities are one of the most common complications of canine liver disease. Symptoms include lethargy, confusion, stupor and altered gait.

Often known as hepatic encephalopathy (HE), this syndrome can have a significant impact on the animal's quality of life.

The causes of this complication in dogs with liver disease is poorly understood and Royal Dick experts say this has made it difficult to develop novel treatments.

Clinicians from Royal Dick partnered with colleagues at RVC to study a range of clinical and biochemical abnormalities that have been linked to HE, using a large sample of dogs with liver disease.

Researchers found both ammonia and inflammation were predictors when it came to the development of HE.

Interestingly, other factors which have been anecdotally tied to the development of the syndrome were discovered not to be associated with neurological abnormalities.

The research team say this work offers an evidence base from which to develop new  treatments. It is hoped these will be able to reduce the incidence and severity of HE.

Royal Dick recently carried out a follow-up study in partnership with Dick White Referrals. The team discovered interleukin-6 (IL-6) concentrations were higher in dogs with cPSS.

Interleukin-6 is believed to be important in mediating neurological disturbances in humans with liver disease.

Researchers are now investigating whether interleukin-6 produces similar effects in dogs.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
BEVA CPD course explores sino-nasal disease

The British Equine Veterinary Association (BEVA) will host a new CPD course exploring the diagnosis of sino-nasal disease.

Led by Safia Barakzai, Henry Tremaine, Justine Kay-Smyth and Neil Townsend, the course aims to support experienced equine vets dealing with nasal discharge cases.

The course will be presented through a series of practical sessions, accompanied by case-based learning. Attendees will be guided to improve their oral examination technique and radiographic approach, as well as learning how to make good use of endoscopy and oroscopy.

BEVA says that learners can combined these skills to perform a 'logical, efficient investigation', with better clinical decision-making and fewer unnecessary steps.

The course will take place on Tuesday, 21 July at the University of Surrey. For more information or to book, visit the BEVA website.